Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 18;3(3):59.
doi: 10.3390/mps3030059.

SARS-CoV-2 Detection for Diagnosis Purposes in the Setting of a Molecular Biology Research Lab

Affiliations

SARS-CoV-2 Detection for Diagnosis Purposes in the Setting of a Molecular Biology Research Lab

Damien Coupeau et al. Methods Protoc. .

Abstract

The emergence of the SARS-CoV-2 virus and the exponential growth of COVID-19 cases have created a major crisis for public health systems. The critical identification of contagious asymptomatic carriers requires the isolation of viral nucleic acids, reverse transcription, and amplification by PCR. However, the shortage of specific proprietary reagents or the lack of automated platforms have seriously hampered diagnostic throughput in many countries. Here, we provide a procedure for SARS-CoV-2 detection for diagnostic purposes from clinical samples in the setting of a basic research molecular biology lab. The procedure details the necessary steps for daily analysis of up to 500 clinical samples with a team composed of 12 experienced researchers. The protocol has been designed to rely on widely available reagents and devices, to cope with heterogeneous clinical specimens, to guarantee nucleic acid extraction from very scarce biological material, and to minimize the rate of false-negative results.

Keywords: COVID-19; RTqPCR; SARS-CoV-2; diagnosis.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1
Type of clinical specimen tubes.
Figure 2
Figure 2
RNA extraction workflow.
Figure 3
Figure 3
PCR loading form.
Figure 4
Figure 4
SARS-CoV-2 PCR amplification curves from successive 10-fold dilutions of a positive sample.
Figure 5
Figure 5
Validation process of the RT-qPCR data.
Figure 6
Figure 6
Timeline of the process.
Figure 7
Figure 7
Anticipated results.

References

    1. Bai Y., Yao L., Wei T., Tian F., Jin D.Y., Chen L., Wang M. Presumed Asymptomatic Carrier Transmission of COVID-19. J. Am. Med. Assoc. 2020;323:1406–1407. doi: 10.1001/jama.2020.2565. - DOI - PMC - PubMed
    1. Corman V.M., Landt O., Kaiser M., Molenkamp R., Meijer A., Chu D.K., Bleicker T., Brünink S., Schneider J., Schmidt M.L. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance. 2020;25:2000045. doi: 10.2807/1560-7917.ES.2020.25.3.2000045. - DOI - PMC - PubMed
    1. Fischer M., Schirrmeier H., Wernike K., Wegelt A., Beer M., Hoffmann B. Development of a pan-Simbu real-time reverse transcriptase PCR for the detection of Simbu serogroup viruses and comparison with SBV diagnostic PCR systems. Virol. J. 2013;10:327. doi: 10.1186/1743-422X-10-327. - DOI - PMC - PubMed
    1. Pan Y., Long L., Zhang D., Yuan T., Cui S., Yang P., Wang Q., Ren S. Potential False-Negative Nucleic Acid Testing Results for Severe Acute Respiratory Syndrome Coronavirus 2 from Thermal Inactivation of Samples with Low Viral Loads. Clin. Chem. 2020;66:794–801. doi: 10.1093/clinchem/hvaa091. - DOI - PMC - PubMed
    1. Artesi M., Long L., Zhang D., Yuan T., Cui S., Yang P., Wang Q., Ren S. A recurrent mutation at position 26,340 of SARS-CoV-2 is associated with failure of the E-gene qRT-PCR utilized in a commercial dual-target diagnostic assay. J. Clin. Microbiol. 2020;66:794–801. doi: 10.1128/JCM.01598-20. - DOI - PMC - PubMed

LinkOut - more resources